BRIEF published on 08/07/2025 at 15:48, 1 year 1 month ago The Vanguard Group Discloses Position in Assura plc Disclosure Takeover Code Vanguard Group Shareholding Assura Plc
PRESS RELEASE published on 08/07/2025 at 15:48, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.65% ownership in Qualcomm Incorporated. Additional disclosure on Alphawave IP Group plc. Transactions involving USD 0.0001 common securities Vanguard Group Ownership Disclosure Securities Transactions Qualcomm Alphawave IP Group
BRIEF published on 08/07/2025 at 15:47, 1 year 1 month ago The Vanguard Group Discloses Stake in Alphawave IP Group Takeover Code Securities Disclosure Vanguard Group Qualcomm Alphawave
PRESS RELEASE published on 08/07/2025 at 15:47, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.62% interest in American Axle & Manufacturing Holdings, Inc. in a Form 8.3 filing. Additional disclosure concerning Dowlais Group plc made Form 8.3 Disclosure Vanguard Group Dowlais Group American Axle
BRIEF published on 08/07/2025 at 15:46, 1 year 1 month ago The Vanguard Group Increases Stake in Deliveroo plc Form 8.3 Vanguard Group Shareholding Disclosure Investment Update Deliveroo Stake
PRESS RELEASE published on 08/07/2025 at 15:46, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc The Vanguard Group, Inc. discloses 3.50% ownership in Dalata Hotel Group plc. No other disclosures made Form 8.3 Irish Takeover Panel The Vanguard Group Ownership Disclosure Dalata Hotel Group
BRIEF published on 08/07/2025 at 15:46, 1 year 1 month ago The Vanguard Group Discloses Stake in Dowlais Group plc Form 8.3 Takeover Code Vanguard Group Stake Disclosure Dowlais Group
PRESS RELEASE published on 08/07/2025 at 15:45, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 4.47% ownership in Mural Oncology plc with 772,339 ordinary shares. Sale of 32 shares at 1.78 USD per unit reported Ordinary Shares The Vanguard Group, Inc. Ownership Disclosure Share Sale Mural Oncology Plc
BRIEF published on 08/07/2025 at 15:45, 1 year 1 month ago The Vanguard Group Discloses Position in Empiric Student Property plc Securities Disclosure Takeover Code Vanguard Group Empiric Student Property
PRESS RELEASE published on 08/07/2025 at 15:44, 1 year 1 month ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses a 5.32% interest in Greencore Group plc per Form 8.3 filing The Vanguard Group, Inc. Form 8.3 Disclosure Interests Greencore Group Plc
Published on 09/12/2026 at 02:35, 22 hours 19 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 1 hour ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 3 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 7 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 7 hours 4 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 17 hours 24 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 2 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 2 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 5 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 17 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 2 days 5 hours ago Availability of the 2026 Interim Financial Report
